Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]

Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)] Publisher Pubmed

Khori V¹ ; Alizadeh AM^{2, 3} ; Khalighfard S^{2, 4} ; Heidarian Y⁵ ; Khodayari H²

Show Affiliations

1. Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
2. Cancer Research Center, Tehran University of Medical Sciences, Tehran, Iran
3. Women Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
5. Department of Biology, Indiana University, Bloomington, 47405, IN, United States

Source: Peptides Published:2023

Abstract

The authors regret to inform that Figure 1D: panel Control.14 day had overlap with panel ATO.21 day at the same figure (Fig. 1D). Correction is done and we have replaced Figure 1D: panel ATO.21 day with the original figure file (attached as Fig. 1D. Panel ATO.21 day). The whole corrected Figure 1D is also attached (Edited Fig. 1D).[Formula presented][Formula presented]. The authors would like to apologise for any inconvenience caused. © 2023 Elsevier Inc.

Style	Citing Format
MLA	Khori V, et al.. "Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]." Peptides, vol. 169, no. , 2023, pp. -.
APA	Khori V, Alizadeh AM, Khalighfard S, Heidarian Y, Khodayari H (2023). Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]. Peptides, 169(), -.
Chicago	Khori V, Alizadeh AM, Khalighfard S, Heidarian Y, Khodayari H. "Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]." Peptides 169, no. (2023): -.
Harvard	Khori V et al. (2023) 'Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]', Peptides, 169(), pp. -.
Vancouver	Khori V, Alizadeh AM, Khalighfard S, Heidarian Y, Khodayari H. Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]. Peptides. 2023;169():-.
BibTex	@article{ author = {Khori V and Alizadeh AM and Khalighfard S and Heidarian Y and Khodayari H}, title = {Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)]}, journal = {Peptides}, volume = {169}, number = {}, pages = {-}, year = {2023} }
RIS	TY - JOUR AU - Khori V AU - Alizadeh AM AU - Khalighfard S AU - Heidarian Y AU - Khodayari H TI - Corrigendum to “Oxytocin Effects on Inhibition of Nf-Κb/Mir195 Pathway in Mice Breast Cancer” [Peptides 107 (2018) 54–60, (S0196978118301396), (10.1016/J.Peptides.2018.07.007)] JO - Peptides VL - 169 IS - SP - EP - PY - 2023 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract